Updates in Systemic Therapy for Renal Cell Carcinoma
Mohamed Ibrahim Mostafa;
Abstract
Renal cell carcinoma (RCC) represents 2-3% of all adult cancers, it is the most common solid malignant lesion within the kidney. Systemic therapy for RCC can be divided into immunotherapy & targeted therapy (angiogenesis inhibitor drugs).
* In locali
* In locali
Other data
| Title | Updates in Systemic Therapy for Renal Cell Carcinoma | Authors | Mohamed Ibrahim Mostafa | Keywords | Updates in Systemic Therapy for Renal Cell Carcinoma | Issue Date | 2011 | Description | Renal cell carcinoma (RCC) represents 2-3% of all adult cancers, it is the most common solid malignant lesion within the kidney. Systemic therapy for RCC can be divided into immunotherapy & targeted therapy (angiogenesis inhibitor drugs). * In locali |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.